ClinVar Miner

Submissions for variant NM_017739.4(POMGNT1):c.681A>G (p.Lys227=)

gnomAD frequency: 0.34915  dbSNP: rs2292487
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 18
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000081805 SCV000113740 benign not specified 2012-07-18 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000081805 SCV000269706 benign not specified 2014-11-26 criteria provided, single submitter clinical testing p.Lys227Lys in exon 8 of POMGNT1: This variant is not expected to have clinical significance because it has been identified in 35% (3000/8600) of European Ameri can chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington. edu/EVS/; dbSNP rs2292487).
PreventionGenetics, part of Exact Sciences RCV000081805 SCV000307105 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000304915 SCV000357999 benign Autosomal recessive limb-girdle muscular dystrophy type 2O 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Illumina Laboratory Services, Illumina RCV000343385 SCV000358000 benign Congenital Muscular Dystrophy, alpha-dystroglycan related 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Athena Diagnostics RCV000576556 SCV000677425 benign not provided 2017-04-14 criteria provided, single submitter clinical testing
Invitae RCV001516894 SCV001725260 benign Autosomal recessive limb-girdle muscular dystrophy type 2O; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 2024-02-01 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001533746 SCV001750535 benign Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 2021-07-01 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001533747 SCV001750536 benign Retinitis pigmentosa 76 2021-07-01 criteria provided, single submitter clinical testing
GeneDx RCV000576556 SCV001856491 benign not provided 2015-03-03 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001789144 SCV002031727 benign Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 2021-10-25 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000304915 SCV002031728 benign Autosomal recessive limb-girdle muscular dystrophy type 2O 2021-10-25 criteria provided, single submitter clinical testing
Dept Of Ophthalmology, Nagoya University RCV003888448 SCV004705233 benign Retinal dystrophy 2023-10-01 criteria provided, single submitter research
Genetic Services Laboratory, University of Chicago RCV000081805 SCV000152348 likely benign not specified no assertion criteria provided clinical testing Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.
Natera, Inc. RCV001275750 SCV001461199 benign Muscle eye brain disease 2020-09-16 no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000081805 SCV001742742 benign not specified no assertion criteria provided clinical testing
Clinical Genetics, Academic Medical Center RCV000081805 SCV001917028 benign not specified no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000081805 SCV001965806 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.